Furthermore, both the baseline and three-month follow-up showed higher levels in obesity participants than in normal-weight participants, indicating that the positive effect of treatment on TNF-α serum levels was offset. This evidence concerns the gene TNF and obesity due to melanocortin 4 receptor deficiency.